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This thesis reports on two murein-
metabolizing enzymes from Escherichia
coli. The two lytic transglycosylases
catalyze the cleavage of the p-L,4-
glycosidic bond between N-
acetylmuramic acid and N-
acetylglucosamine in the murein-
polymer, yielding muropeptides with ^
1,6-anhydro-muramic acid residue.
Studies on bacterial transglycosylases
are of interest for at least three reasons.
In the first place, such studies contribute
to a better understanding of the
metabolism of murein. In the second
place, these enzymes can be used for the
production of pharmacologically active
compounds by specific degradation of
murein in vitro. In the third place, a 3D-
structure might lead to the design of
selective inhibitors and thus to the
development of a new class of
antibiotics.
Chapter 1 gives an introduction
concerning murein-metabolism, the
specific activities of murein hydrolases
with emphasis on the lytic
transglycosylases, and the biological
activities of muropeptides with emphasis
on 1,6-anhydro-muropeptides.
In Chapter 2, we describe the
nucleotide sequence and overexpression
of the s/r gene encoding the soluble lytic
transglycosylase (Slt70) with a molecular
mass of 70 kDa. A 250-fold
overproduction was tolerated by the
bacterial cell and has resulted in a
simplified purification procedure for the
purification of Slt70 in 100 mg amounts.
Chapter 3 reports on the nucleotide
sequence and overexpression of the mlt
gene which was supposed to encode the
second lytic transglycosylase, being
membrane-bound (Mlt), with a molecular
mass of 35 kDa. However, a 500-fold
overproduction of Mlt did not result in a
parallel increase in murein hydrolase
activity. This has led to the suggestion
that we are most likely not dealing with a
gene that encodes a lytic transglycosylase
but a cytoplasmic membrane-bound
protein with unknown function.
In Chapter 4, we describe the solution
of the problem discussed in Chapter 3. A
second soluble lytic transglycosylase
(Slt35), with a molecular mass of 35
kDa, was purified from an E. coli strain
which was chromosomally deleted for the
slt gene encoding Slt70. Polyclonal
antibodies, previously being raised
against Mlt, cross-react with Slt35
indicating that Slt35 was present in the
Mlt-preparations in addition to a
cytoplasmic membrane-bound protein of
35 kDa. Therefore, the second
transglycosylase in E. coli is not a
membrane-bound protein as was stated
earlier.
Chapter 5 describes the crystallization
of Slt70. The crvstals diffract in the X-
ray beam to 2.8 Á resolution.
The complete 3D-structure of Slt70 has
been determined recently (see cover) by
Andy-Mark Thunnissen in the group of
Bauke Dijkstra at the Department of
Chemical Physics at the University of
Groningen. Slt70 consists of two
domains. The N-terminal 360 amino
acids represent a non-globular domain
with a horse-shoe-like structure and
possesses exclusively a-helices as
secondary structure elements. The C-
terminal domain (amino acid 384 to 618)
is a globular domain and shows
structural similarity to T4-lysozyme
which has already resulted in the










































residues. This C-terminal domain does
not cover the hole in the N-terminal
domain. This enormous hole in the
protein, with a diameter of about 25 4,,
has led to the speculation that at least
one and possibly two sugar chains are
passing through the hole. Whether Slt70
degrades in vivo one sugar chain or two
crosslinked chains, or maybe even two
chains connects. will be studied in the
near future.
The enormous difference in the
molecular masses of Slt70 and Slt35 and
the similarity of the N-termtnal26 amino
acids of Slt35 with a stretch of amino
acids in the middle of the primary
structure of Slt70, suggest that slt35 is
lacking a domain similar to the N-
terminal domain of S1t70. Cloning of the
gene encoding Slt35, its nucleotide
sequence, and 3D-structure of Slt35
might prove this.
The biotechnological part of this thesis
is described in Chapter 6, 7, and 8. For
quantitative degradation of the murein
polymer to the monomeric sleep-inducing
1,6-anhydro-muropeptides, a combined
digestion of the isolated polymer with a
transglycosylase and at least one of the
two murein endopeptidases (PBP4 and
MepA) is essential. In order to develop a
simple batch procedure for the large-
scale production of 1,6-anhydro-
muropeptides, the purification of the
hydrolases had to be simplified and
multiple use of the enzymes had to be
achieved by immobilizing them on a
matrix. Both demands could be fulfilled
by construction and overexpression of the
murein hydrolases as Staphylococcal
Protein A gene fusions. The N-terminal
domain of Protein A consists of five
regions possessing high affinity to the F"
part of IgG.
Chapter 6 reports on the construction
of a suitable vector for the controlled
high-level overproduction of
Staphylococcal Protein A (SpA) fusion
proteins in the periplasm of E. coli. This
vector is used in Chapter 7 for the
overproduction of Slt, PBP4, ild MepA
as SpA fusion proteins. The SpA fusion
proteins were stably overproduced and
account for 5, 5, and 0.5 mg/liter culture
for SpASlt, SpAPBP4, and SpAMepA,
respectively.
The stability of the SpA fusion proteins
in vitro as well as the in batch
degradation of murein, and purification
of the 1,6-anhydro-muropeptides Íre
described in Chapter 8. The SpA fusion
proteins, immobilized on IgG Sepharose,
are proteolytically sensitive, which
resulted in a complete degradation of the
SpA portion of the fusion proteins
thereby releasing the murein hydrolases
in intact and enzymatically active form
into the supernatant. Proteolytic
degradation could be prevented by
PHMB or EDTA. In the presence of
PHMB, the immobilized fusion proteins
were enzymatically active and could be
used for the batch production of
biologically active 1,6-anhydro-
muropeptides, which successively were
separated by HPLC.
